skin condition

Patients

Chronic skin conditions, particularly CHE, remain some of the most underestimated, yet pervasive, challenges affecting people across Europe.

News

The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis

News

According to multiple press reports citing anonymous insider sources, Dr Martin Makary has resigned after a year at the head of the FDA.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.